Aurora Cannabis (TSE:ACB) Shares Up 6%

Shares of Aurora Cannabis Inc. (TSE:ACB – Get Rating) were up 6% during mid-day trading on Friday . The company traded as high as C$0.88 and last traded at C$0.88. Approximately 280,464 shares changed hands during trading, a decline of 70% from the average daily volume of 943,743 shares. The stock had previously closed at C$0.83.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on ACB shares. Jefferies Financial Group reduced their price target on shares of Aurora Cannabis from C$1.80 to C$1.31 in a research report on Tuesday, February 28th. Stifel Nicolaus cut their price target on Aurora Cannabis from C$1.45 to C$1.20 in a report on Monday, February 13th. Canaccord Genuity Group lowered their price objective on shares of Aurora Cannabis from C$2.00 to C$1.50 in a research note on Friday, February 10th. Finally, CIBC cut their target price on shares of Aurora Cannabis from C$2.25 to C$1.75 and set a “neutral” rating on the stock in a research note on Monday, February 13th. Six investment analysts have rated the stock with a hold rating, According to data from MarketBeat, Aurora Cannabis presently has an average rating of “Hold” and a consensus price target of C$2.22.

Aurora Cannabis Stock Up 7.2 %

The company has a debt-to-equity ratio of 38.00, a quick ratio of 2.48 and a current ratio of 4.08. The business’s 50 day simple moving average is C$0.88 and its 200-day simple moving average is C$1.23. The company has a market cap of C$303.48 million, a price-to-earnings ratio of -0.12 and a beta of 3.00.

About Aurora Cannabis

(Get Rating)

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, Caribbeans, South America, and Israel; and distribution and sale of hemp-derived cannabidiol (CBD) products in the United States (U.S.) market.